(Q45874509)

17 December 2017

title

Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines (English)

1 reference

17 December 2017

0 references

C E Walsh

1

1 reference

17 December 2017

Adult Prophylaxis Study Group

series ordinal

2

1 reference

17 December 2017

publication date

14 January 2008

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

385-386

1 reference

17 December 2017

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01614.X

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01614.X

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01614.X

Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01614.X

Long-term major joint outcomes in young adults with haemophilia: interim data from the HGDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01614.X

10.1111/J.1365-2516.2007.01614.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017